Overmedication associated with these many secondary complications
To control or reduce some of these so-called secondary complication and diseases, patients suffering a SCI are found to use a plethora of symptomatic drug treatments. Indeed, it has been reported recently that as many as three hundred (300) different medicines belonging to nineteen different classes are regularly administered to chronic SCI patients [10] . Among them, drugs against bowel and bladder problems, blood cloth/deep venous thrombosis, cardiovascular problems, depression/anxiety, stomach acidity, infections, pain, inflammation, sleeping problems and vitamin deficiency are commonly used after chronic SCI [10] . Given that many of these problems are associated largely with chronic physical inactivity, a therapy capable of enabling the recovery of treadmill training, for instance, could potentially constitute an interesting approach against many of these secondary complications.
A first oral pill in development for metabolically challenging, drug-induced exercising after SCI
Engaging actively most large muscle groups for relatively intense contractions is one of the main basic principles underlying cardiovascular training capable of metabolic benefits (www.rcmp-grc.gc.ca; www.cdc. gov/physicalactivity). As of now, a drug candidate called Spinalon TM is probably one of the most promising solutions enabling challenging physical activity to be induced after SCI.
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It is an oral tritherapy composed of buspirone/levodopa/ carbidopa shown first in paraplegic mice to induce, within a few minutes post-administration, 30-45 min episodes of self-weight bearing walking on a treadmill [11] . It has recently undergone successfully, at the Montreal General Hospital/McGill University Health Center, a randomized double-blind study in 45 subjects suffering a SCI (https:// clinicaltrials.gov/ct2/show/NCT01484184). It does not repair the spinal cord but, instead, potently reactivates the spinal network for locomotion typically located in L1-L2 level -below injury level in most cases. Administered between 3 and 5 times/week for a few weeks in paraplegic mice, Spinalon TM successfully prevented bone loss, muscular atrophy, immune system deficiency, and anemia normally found after SCI [12, 13] .
Concluding remarks
Overmedication is undoubtedly an underrated problem associated with aging and other chronic conditions such as SCI and related debilitating diseases. Many of those symptomatic drugs prescribed to SCI patients could potentially be avoided or their doses significantly reduce if those patients were capable of being engaged regularly into metabolically challenging workouts on a treadmill. Indeed, regular exercising is well-known to improve general health and vital functions that are typically impaired after paralysis. Consequently, if Spinalon TM were to be approved by authorities, pending upon results from the phase II/III trials, it may become a relatively simple holistic approach against overmedication in patients with SCI.
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